|
Dimension 2: Crude and adjusted associations between patient characteristics and patients' evaluation of aspects of the medical care. |
|||||||||
| 100% positive assessments 1 |
0–49% positive assessments 2 |
||||||||
|
|
|||||||||
| Prev.(%) |
PR |
Adj. PR |
95% CI |
Prev.(%) |
PR |
Adj. PR |
95% CI |
||
|
|
|||||||||
| Gender |
|||||||||
| (N = 25377) |
Female |
61.2 |
1 |
13 |
19.4 |
1 |
1 |
||
| Male |
61.2 |
1.00 |
0.95 |
0.93 – 0.97 |
19.2 |
0.99 |
1.06 |
1.00 – 1.13 |
|
|
|
|||||||||
| Age (years) |
|||||||||
| (N = 25377) |
18–24 |
47.8 |
1 |
13 |
26.2 |
1 |
1 |
||
| 25–29 |
52.3 |
1.09 |
1.07 |
0.99 – 1.16 |
23.2 |
1.03 |
0.92 |
0.82 – 1.04 |
|
| 30–34 |
56.8 |
1.19 |
1.18 |
1.10 – 1.26 |
21.6 |
1.00 |
0.84 |
0.75 – 0.93 |
|
| 35–39 |
56.3 |
1.18 |
1.20 |
1.13 – 1.29 |
21.8 |
1.01 |
0.79 |
0.71 – 0.88 |
|
| 40–44 |
57.7 |
1.21 |
1.29 |
1.19 – 1.38 |
20.9 |
1.00 |
0.71 |
0.63 – 0.79 |
|
| 45–49 |
57.5 |
1.20 |
1.31 |
1.22 – 1.41 |
21.9 |
0.90 |
0.70 |
0.62 – 0.78 |
|
| 50–54 |
61.1 |
1.28 |
1.44 |
1.33 – 1.55 |
19.0 |
0.88 |
0.57 |
0.50 – 0.65 |
|
| 55–59 |
64.5 |
1.35 |
1.55 |
1.43 – 1.66 |
17.9 |
0.74 |
0.52 |
0.46 – 0.60 |
|
| 60–64 |
67.1 |
1.40 |
1.61 |
1.50 – 1.73 |
15.6 |
0.67 |
0.45 |
0.40 – 0.52 |
|
| 65–69 |
73.0 |
1.53 |
1.76 |
1.64 – 1.88 |
13.1 |
0.58 |
0.38 |
0.33 – 0.45 |
|
| 70–74 |
71.4 |
1.49 |
1.73 |
1.61 – 1.86 |
14.9 |
0.53 |
0.43 |
0.38 – 0.50 |
|
| 75–79 |
70.1 |
1.47 |
1.73 |
1.61 – 1.85 |
14.8 |
0.51 |
0.42 |
0.36 – 0.48 |
|
| 80+ |
69.8 |
1.46 |
1.73 |
1.60 – 1.87 |
15.6 |
0.57 |
0.42 |
0.36 – 0.50 |
|
|
|
|||||||||
| Further education (years) |
|||||||||
| (N = 24220) |
None |
60.2 |
1 |
13 |
19.6 |
1 |
1 |
||
| Less than 2 |
60.4 |
1.01 |
1.03 |
0.99 – 1.07 |
20.8 |
1.06 |
1.04 |
0.94 – 1.16 |
|
| 2–4 |
61.5 |
0.91 |
1.02 |
0.99 – 1.05 |
19.1 |
0.97 |
1.02 |
0.95 – 1.10 |
|
| 5 or more |
61.2 |
0.80 |
1.00 |
0.97 – 1.04 |
18.8 |
0.96 |
1.03 |
0.93 – 1.14 |
|
| Undergoing education or other |
61.4 |
0.90 |
1.07 |
1.02 – 1.12 |
17.3 |
0.88 |
0.85 |
0.74 – 0.97 |
|
|
|
|||||||||
| Frequency of attendance (times per year) |
|||||||||
| (N = 25377) |
0–1 |
64.2 |
1 |
13 |
19.0 |
1 |
1 |
||
| 2–3 |
60.9 |
0.95 |
0.98 |
0.95 – 1.01 |
19.2 |
1.01 |
0.96 |
0.88 – 1.05 |
|
| 4–5 |
61.9 |
0.96 |
1.01 |
0.98 – 1.05 |
19.3 |
1.02 |
0.92 |
0.84 – 1.01 |
|
| 6–7 |
60.0 |
0.94 |
1.01 |
0.98 – 1.06 |
19.3 |
1.02 |
0.85 |
0.77 – 0.94 |
|
| 8–9 |
60.6 |
0.94 |
1.04 |
1.00 – 1.09 |
19.5 |
1.03 |
0.82 |
0.73 – 0.92 |
|
| 10+ |
60.1 |
0.94 |
1.09 |
1.04 – 1.14 |
19.8 |
1.04 |
0.74 |
0.67 – 0.83 |
|
|
|
|||||||||
| Duration of listing (years) |
|||||||||
| (N = 16880) |
Less than 1 |
60.5 |
1 |
13 |
20.3 |
1 |
1 |
||
| 1–2 |
62.7 |
1.04 |
1.01 |
0.96 – 1.07 |
18.4 |
0.91 |
0.99 |
0.86 – 1.12 |
|
| 3–7 |
61.2 |
1.01 |
0.96 |
0.91 – 1.01 |
19.0 |
0.93 |
1.05 |
0.93 – 1.18 |
|
| 8–12 |
62.4 |
1.03 |
0.96 |
0.90 – 1.01 |
19.1 |
0.94 |
1.11 |
0.98 – 1.27 |
|
| 13+ |
65.8 |
1.09 |
1.00 |
0.94 – 1.06 |
16.0 |
0.79 |
0.94 |
0.83 – 1.08 |
|
|
|
|||||||||
| Self-rated health |
|||||||||
| (N = 25377) |
Excellent |
71.8 |
1 |
13 |
13.4 |
1 |
1 |
||
| Very good |
64.8 |
0.90 |
0.86 |
0.83 – 0.89 |
15.7 |
1.17 |
1.27 |
1.14 – 1.43 |
|
| Good |
61.1 |
0.85 |
0.72 |
0.70 – 0.75 |
19.2 |
1.43 |
1.90 |
1.69 – 2.13 |
|
| Fair |
52.4 |
0.73 |
0.59 |
0.56 – 0.61 |
26.5 |
1.97 |
2.94 |
2.60 – 3.31 |
|
| Poor |
48.2 |
0.67 |
0.53 |
0.49 – 0.58 |
30.2 |
2.25 |
3.43 |
2.96 – 3.97 |
|
|
|
|||||||||
| Chronic condition |
|||||||||
| (N = 25017) |
No |
64.6 |
1 |
13 |
18.6 |
1 |
1 |
||
| Yes-KRTC |
67.9 |
1.10 |
1.09 |
1.06 – 1.12 |
15.9 |
0.86 |
0.84 |
0.77 – 0.92 |
|
| Yes-other or multiple |
57.1 |
0.93 |
1.01 |
0.98 – 1.04 |
22.2 |
1.19 |
0.96 |
0.90 – 1.02 |
|
|
|
|||||||||
| Chronic condition |
|||||||||
| (N = 17058) |
61.6 |
1 |
13 |
18.6 |
1 |
1 |
|||
| K – Cardiovascular |
70.6 |
1.15 |
1.12 |
1.08 – 1.16 |
13.7 |
0.73 |
0.76 |
0.67 – 0.87 |
|
| R – Respiratory |
60.6 |
0.98 |
1.05 |
0.99 – 1.10 |
19.4 |
1.04 |
0.90 |
0.79 – 1.04 |
|
| T – Endocrine |
68.2 |
1.11 |
1.11 |
1.06 – 1.16 |
17.9 |
0.96 |
0.94 |
0.81 – 1.08 |
|
| C – Cancer |
75.2 |
1.22 |
1.28 |
1.19 – 1.37 |
11.7 |
0.63 |
0.55 |
0.39 – 0.77 |
|
|
Prevalence ratio (PR) for 100% positive assessments and for 0–49% positive assessments associated with different patient characteristics. Crude PRs are adjusted for clustering of patients. Adjusted PRs are adjusted for patients' gender, age, frequency of attending a GP, self -rated health and clustering of frequency patients. Numbers in italics are used to indicate statistical significance. 1 Patients who marked 100% of the answered questions in one of the two most positive answering categories. 2 Patients who marked less than 50% (0–49%) of the answered questions in one of the two most positive answering categories. 3 Poisson regression with robust variance | |||||||||
Heje et al. BMC Health Services Research 2008 8:178 doi:10.1186/1472-6963-8-178 |
|||||||||